MBX Biosciences Revenue and Competitors

Carmel, IN USA

Location

#1660

Growjo Ranking

Estimated Revenue & Valuation

  • MBX Biosciences's estimated annual revenue is currently $4.6M per year.(i)
  • MBX Biosciences's estimated revenue per employee is $112,000

Employee Data

  • MBX Biosciences has 41 Employees.(i)
  • MBX Biosciences grew their employee count by 71% last year.

MBX Biosciences's People

NameTitleEmail/Phone
1
Interim Chief Medical Officer, MBX BiosciencesReveal Email/Phone
2
Chief Human Resources OfficerReveal Email/Phone
3
VP Global Regulatory AffairsReveal Email/Phone
4
VP Clinical DevelopmentReveal Email/Phone
5
VP, CMCReveal Email/Phone
6
VP, Global Regulatory AffairsReveal Email/Phone
7
VP Pharmacology and ToxicologyReveal Email/Phone
8
VP, MarketingReveal Email/Phone
9
VP, Clinical DevelopmentReveal Email/Phone
10
VP MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$750M27040%$14MN/A
#2
$25.4M16921%$42MN/A
#3
$13.9M9922%N/AN/A
#4
$1.2M1417%N/AN/A
#5
$39.6M2636%$49.3MN/A
#6
$3.6M3214%N/AN/A
#7
$13.3M95-10%$42.4MN/A
#8
$25.4M16921%$42MN/A
#9
$498.5M24905%$28.5MN/A
#10
$2.3M235%N/AN/A
Add Company

What Is MBX Biosciences?

MBX Biosciences is a preclinical-stage biotech company committed to creating therapies to treat rare endocrine diseases where there is inadequate treatment available. MBX's leadership team has collaborated successfully over several decades to discover, develop and commercialize first-in-class endocrine therapeutics. A distinguishing strength of MBX is world-class proprietary peptide drug discovery.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$4.6M

Revenue (est)

71%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MBX Biosciences News

2022-04-13 - MBX Biosciences Hires Chief Financial Officer

Carmel-based MBX Biosciences has hired Richard Bartram as chief financial officer. He most recently was chief financial officer at Esperion...

2022-04-13 - MBX Biosciences Names CFO

- Carmel-based biopharmaceutical company MBX Biosciences Inc. has named Richard Bartram chief financial officer. Bartram most recently served as...

2022-04-06 - MBX Biosciences Appoints Ora Hirsch Pescovitz, MD, to

MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.1M41-9%N/A
#2
$6.9M41-52%N/A
#3
$4.9M410%N/A
#4
$6.9M41-5%N/A
#5
$9.1M42-21%N/A